Voelkel NF - Search Results

1

Treatment of severe pulmonary hypertension: a bradykinin receptor 2 agonist B9972 causes reduction of pulmonary artery pressure and right ventricular hypertrophy.

Taraseviciene-Stewart L, Scerbavicius R, Stewart JM, Gera L, Demura Y, Cool C, Kasper M, Voelkel NF. Taraseviciene-Stewart L, et al. Among authors: voelkel nf. Peptides. 2005 Aug;26(8):1292-300. doi: 10.1016/j.peptides.2005.03.050. Peptides. 2005. PMID: 15878794

2

A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model.

Taraseviciene-Stewart L, Gera L, Hirth P, Voelkel NF, Tuder RM, Stewart JM. Taraseviciene-Stewart L, et al. Among authors: voelkel nf. Can J Physiol Pharmacol. 2002 Apr;80(4):269-74. doi: 10.1139/y02-047. Can J Physiol Pharmacol. 2002. PMID: 12025960

3

Pathology of pulmonary hypertension.

Voelkel NF, Cool C. Voelkel NF, et al. Cardiol Clin. 2004 Aug;22(3):343-51, v. doi: 10.1016/j.ccl.2004.04.010. Cardiol Clin. 2004. PMID: 15302355 Review.

4

Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension.

Achcar RO, Demura Y, Rai PR, Taraseviciene-Stewart L, Kasper M, Voelkel NF, Cool CD. Achcar RO, et al. Among authors: voelkel nf. Chest. 2006 Mar;129(3):696-705. doi: 10.1378/chest.129.3.696. Chest. 2006. PMID: 16537870

5

Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.

Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Cool C, Wood K, Tuder RM, Burns N, Kasper M, Voelkel NF. Taraseviciene-Stewart L, et al. Among authors: voelkel nf. Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L668-76. doi: 10.1152/ajplung.00491.2005. Epub 2006 May 12. Am J Physiol Lung Cell Mol Physiol. 2006. PMID: 16698853 Free article.

6

N-acetylcysteine treatment protects against VEGF-receptor blockade-related emphysema.

Demura Y, Taraseviciene-Stewart L, Scerbavicius R, Tuder RM, Voelkel NF. Demura Y, et al. Among authors: voelkel nf. COPD. 2004 Apr;1(1):25-32. doi: 10.1081/COPD-120030412. COPD. 2004. PMID: 16997736 Free article.

7

The cancer paradigm of severe pulmonary arterial hypertension.

Rai PR, Cool CD, King JA, Stevens T, Burns N, Winn RA, Kasper M, Voelkel NF. Rai PR, et al. Among authors: voelkel nf. Am J Respir Crit Care Med. 2008 Sep 15;178(6):558-64. doi: 10.1164/rccm.200709-1369PP. Epub 2008 Jun 12. Am J Respir Crit Care Med. 2008. PMID: 18556624 Free PMC article.

8

Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension.

Voelkel NF, Cool C, Taraceviene-Stewart L, Geraci MW, Yeager M, Bull T, Kasper M, Tuder RM. Voelkel NF, et al. Crit Care Med. 2002 May;30(5 Suppl):S251-6. doi: 10.1097/00003246-200205001-00013. Crit Care Med. 2002. PMID: 12004244 Review.

9

Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats.

Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Gera L, Tuder RM, Voelkel NF. Choe KH, et al. Among authors: voelkel nf. Am J Respir Crit Care Med. 2003 Jun 1;167(11):1516-21. doi: 10.1164/rccm.200210-1207OC. Epub 2003 Jan 9. Am J Respir Crit Care Med. 2003. PMID: 12522028

10

Circulating endothelial cells in pulmonary hypertension.

Bull TM, Golpon H, Hebbel RP, Solovey A, Cool CD, Tuder RM, Geraci MW, Voelkel NF. Bull TM, et al. Among authors: voelkel nf. Thromb Haemost. 2003 Oct;90(4):698-703. doi: 10.1160/TH03-04-0251. Thromb Haemost. 2003. PMID: 14515191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters